{"id":1066078,"date":"2022-03-29T12:57:42","date_gmt":"2022-03-29T16:57:42","guid":{"rendered":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/uncategorized\/the-effect-of-post-brexit-status-on-clinical-trial-logistics-clinical-trials-arena\/"},"modified":"2022-03-29T12:57:42","modified_gmt":"2022-03-29T16:57:42","slug":"the-effect-of-post-brexit-status-on-clinical-trial-logistics-clinical-trials-arena","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/brexit\/the-effect-of-post-brexit-status-on-clinical-trial-logistics-clinical-trials-arena\/","title":{"rendered":"The effect of post-Brexit status on clinical trial logistics &#8211; Clinical Trials Arena"},"content":{"rendered":"<p><p>Regional Focus: In the Front Lines of Clinical Trials   <\/p>\n<p>Oximio is a well-established clinical trials service provider that helps researchers around the world discover effective treatments and cures for medical needs. With a global presence spanning regions such as the UK, Eastern Europe, Western Asia, and South Africa, Oximio harnesses a deep understanding of a range of international clinical trial markets. Focusing on its Eastern European operations, this whitepaper provides an overview of the Russian, Georgian and Ukranian clinical trial landscape, including discussions of the unique advantages and opportunities that each market presents.The whitepaper explores the local regulations and legislation that govern clinical research in these markets, as well as the steps and processes that researchers must take to secure approval and register drugs there. The key services provided by Oximio to support clinical trials in these countries are also detailed, including fact sheets on the service providers local depots, capacities and operational timelines.<\/p>\n<p>By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Oximio privacy policy<\/p>\n<p>By downloading this Whitepaper, you acknowledge that we may share your information with our white paper partners\/sponsors who may contact you directly with information on their products and services.<\/p>\n<p>Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.  Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.<\/p>\n<p>Thank you.Please check your email to download the Whitepaper.   <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the rest here: <\/p>\n<p><a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.clinicaltrialsarena.com\/sponsored\/the-effect-of-post-brexit-status-on-clinical-trial-logistics\/\" title=\"The effect of post-Brexit status on clinical trial logistics - Clinical Trials Arena\">The effect of post-Brexit status on clinical trial logistics - Clinical Trials Arena<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Regional Focus: In the Front Lines of Clinical Trials Oximio is a well-established clinical trials service provider that helps researchers around the world discover effective treatments and cures for medical needs. With a global presence spanning regions such as the UK, Eastern Europe, Western Asia, and South Africa, Oximio harnesses a deep understanding of a range of international clinical trial markets.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/brexit\/the-effect-of-post-brexit-status-on-clinical-trial-logistics-clinical-trials-arena\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[411165],"tags":[],"class_list":["post-1066078","post","type-post","status-publish","format-standard","hentry","category-brexit"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1066078"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=1066078"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1066078\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=1066078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=1066078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=1066078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}